Studie
Resveratrol and immunomodulation: tabular summary of human trial endpoints
TABULAR REVIEW OF RESVERATROL EFFECTS ON IMMUNE AND INFLAMMATORY ENDPOINTS ACROSS HUMAN STUDIER
Tier 3
2026
A tabular review of resveratrol's inflammatory and immune endpoints across published human studies.
StudiedesignTABULAR REVIEW OF RESVERATROL EFFECTS ON IMMUNE AND INFLAMMATORY ENDPOINTS ACROSS HUMAN STUDIER
TierNivå 3, Blandad humana bevis, mekanism trovärdig
År2026
TidskriftFrontiers in Immunology
Publiceradjan 14, 2026
Tillagd i NO1GEVITYjun 28, 2026
Det här är en översikt med många tabeller över hur resveratrol faktiskt har påverkat inflammationsmarkörer och immunutfall i studier på människor. The recurring signals are modest reductions in CRP and TNF-alpha in metabolic populations, mixed effects in healthy adults, and no clear effect on infection incidence. Useful mainly as a reference for someone trying to reconcile positive-vs-null endpoints across studies.
Resveratrol's inflammatory endpoint effects are consistent in metabolic subgroups and inconsistent in healthy adults.
Kritikernoter
Not a formal metaanalys. The table combines primär and secondary endpoints across studies of very different design.
Citerad av
1 encyklopediartiklar refererar till denna studie.